Results 31 to 40 of about 19,199 (220)

Regular use of non-steroidal anti-inflammatory drugs can effectively control pain and global health in patients with moderate activity of rheumatoid arthritis

Современная ревматология, 2021
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used to control pain in rheumatoid arthritis (RA). However, many aspects of the therapeutic effect of NSAIDs in RA have not been sufficiently studied.
A. E. Karateev, E. Yu. Pogozheva, V. N. Amirdzhanova, E. S. Filatova, V. A. Nesterenko   +4 more
doaj   +1 more source

AB0305 Remaining foot synovitis may predict relapse in rheumatoid arthritis patients in das28 remission (DAS28-CRP<2.3) [PDF]

Annals of the Rheumatic Diseases, 2018
Background DAS28 (Disease Activity Score based on 28 joints) is widely used to determine remission in rheumatoid arthritis (RA). The problems with DAS28 due to omission of the lower extremity joints have long been discussed. There are reports demonstrating that some patients meeting DAS28 remission criteria still have synovitis in their feet.1 It is ...
S. Hattori, N. Hagino, K. Yomono, S. Tsuzuki, S. Suzuki, S. Takenouchi, R. Yokochi, T. Matsui, S. Tohma   +8 more
openaire   +1 more source

DYNAMICS OF CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS AS INFLUENCED BY INFLIXIMAB (REMIKEID) ADMINISTRATION

Медицинская иммунология, 2014
. Rheumatoid arthritis (RA) is a chronic autoimmune systemic disease with predominantly destructive lesions of peripheral joints, with prevalence of 0.6 to 1.6% in general population.
E. S. Zhugrova, V. I. Mazurov, A. M. Lila, K. A. Syssoev, S. V. Lapin, Areg A. Totolian   +5 more
doaj   +1 more source

Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT

Health Technology Assessment, 2018
Background: Rheumatoid arthritis (RA), the most common autoimmune disease in the UK, is a chronic systemic inflammatory arthritis that affects 0.8% of the UK population.
Sarah Brown, Colin C Everett, Kamran Naraghi, Claire Davies, Bryony Dawkins, Claire Hulme, Christopher McCabe, Sue Pavitt, Paul Emery, Linda Sharples, Maya H Buch   +10 more
doaj   +1 more source

Clinical efficacy of the rituximab biosimilar Acellbia® 600 mg in patients with active rheumatoid arthritis in clinical practice

Научно-практическая ревматология, 2019
Objective: to evaluate the clinical efficacy of the rituximab biosimilar Acellbia® at a dose of 600 mg intravenously at a 2-week interval in patients with active rheumatoid arthritis (RA) 12 and 24 weeks after initiation of treatment.Subjects and methods.
D. A. Kusevich, A. S. Avdeeva, V. V. Rybakova, N. V. Chichasova, E. L. Nasonov   +4 more
doaj   +1 more source

Performance and correlation of DAS28-MCP-1 with DAS28.

, 2013
Correlation analysis was performed by estimating Pearson’s correlation coefficients for 111 patients with rheumatoid arthritis, including 48 newly diagnosed (blood drawn four times in a 6-month period) patients and 63 patients undergoing standard ...
Lieh-bang Liou (286162), Chee J. Chang (286165), Wan-ju Chao (286166), Meng-hsin Chen (286168), Wen-pin Tsai (286164)   +4 more
core   +1 more source

Fit of the predicted DAS28 to the observed DAS28.

, 2016
Fit of the predicted DAS28 to the observed DAS28.
Sandhya C. Nair (3177129), Johannes W. J. Bijlsma (833467), Z. Nazira Jahangier (3177132), Johannes W. G. Jacobs (3177126), Jacobs M. van Laar (3177120), Marije F. Bakker (3177123), Floris P. J. G. Lafeber (552927), Paco M. J. Welsing (833464)   +7 more
core   +1 more source

Análisis del componente subjetivo del DAS28 en dos poblaciones de América del Sur con artritis reumatoide en tratamiento con agentes biológicos

Revista Paraguaya de Reumatología, 2020
Introducción: La actividad de la enfermedad en los pacientes con artritis reumatoide (AR) es frecuentemente determinada utilizando el índice compuesto DAS28.
Magali Zanotti, Gabriela Ávila-Pedretti, Paloma de Abreu   +2 more
doaj  

Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies [PDF]

Rheumatology International, 2020
AbstractAssessment of individual therapeutic responses provides valuable information concerning treatment benefits in individual patients. We evaluated individual therapeutic responses as determined by the Disease Activity Score-28 joints critical difference for improvement (DAS28-dcrit) in rheumatoid arthritis (RA) patients treated with intravenous ...
Köhm, Michaela, McIntosh, Matthew J., Hofmann, Michael W., Abraham, Varghese, Gabay, Cem, Choy, Ernest H., Kavanaugh, Arthur, Burkhardt, Harald, Behrens, Frank   +8 more
openaire   +5 more sources

Efficacy and Safety of Ozoralizumab vs. Moxibustion for Rheumatoid Arthritis

Folia Medica Indonesiana
Rheumatoid arthritis is a chronic inflammatory disease that symmetrically damages the synovial membrane, affecting approximately 13% of the global population.
Luthfiana Rofhani Susanti, Arifa Mustika, Lita Diah Rahmawati, Citrawati Dyah Kencono Wungu   +3 more
doaj   +1 more source